Owner OSI Pharmaceuticals, Inc.

Inventors Newton, Gary; Thomas, Claire; Dawson, Graham; Li, An-Hu; Wynne, Graham Michael; Saba, Imaad; Doyle, Kevin; Crew, Andrew Philip; Sadiq, Shazia; Keily, John Fraser; Ahmed, Saleh; Pegg, Neil Anthony; Castelano, Arlindo Lucas; Smyth, Don; Rasamison, Chrystelle

Agent Spruson & Ferguson

Pub. Number AU-B-2004204135

PCT Pub. Number WO2004/063330

Priority 60/526,358 02.12.03 US; 60/438,152 06.01.03 US; 60/524,972 25.11.03 US

Filing date 6 January 2004

Wipo publication date 29 July 2004

Acceptance publication date 11 February 2010

C07D 409/12 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms

A61K 31/381 (2006.01) - having five-membered rings

A61K 31/437 (2006.01)

A61K 31/4436 (2006.01)

A61K 31/4709 (2006.01) - Non-condensed quinolines containing further heterocyclic rings

A61K 31/4745 (2006.01)

C07D 409/14 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms

C07D 471/04 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups